What is the current Global Single-cell Genome Sequencing Market size?

The Global Single-cell Genome Sequencing Market is projected to register a CAGR of 15.20% during the forecast period (2024-2029) Read More

Who are the key players in Global Single-cell Genome Sequencing Market?

QIAGEN, Fluidigm Corporation, Illumina, Inc., F. Hoffmann-La Roche Ltd. and ThermoFisher Scientific, Inc. are the major companies operating in the Global Single-cell Genome Sequencing Market. Read More

Which is the fastest growing region in Global Single-cell Genome Sequencing Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Single-cell Genome Sequencing Market?

In 2024, the North America accounts for the largest market share in Global Single-cell Genome Sequencing Market. Read More

What years does this Global Single-cell Genome Sequencing Market cover?

The report covers the Global Single-cell Genome Sequencing Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Single-cell Genome Sequencing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Single-cell Genome Sequencing Market

Single-cell Genome Sequencing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Genome Sequencing Companies and the market is segmented by Product (Instruments and Reagents), Technology (Sequencing, PCR, Microarray, and Others), Disease Area (Cancer, Immunology, Microbiology, and Others), End User (Biotechnology & Biopharmaceutical Companies, Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Single-cell Genome Sequencing Industry Overview

The market is partially fragmented and consists of several major players. Some companies currently dominating the market are Fluidigm Corporation, QIAGEN, Illumina, Inc., F. Hoffmann-La Roche Ltd., and ThermoFisher Scientific, Inc.